


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.05%
+2.97%
+3.24%
+4.68%
+3.69%
RGEN
Repligen Corporation
$167.93
Strengths

Earnings are forecast to grow
RGEN Price Performance
$166.36 (+0.94%)
$161.1 (+4.24%)
$122.17 (+37.46%)
$161.86 (+3.75%)
RGEN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
RGEN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RGEN Street Sentiment is extremely bullish and have negative views on the near-term outlook
RGEN has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
What is RGEN current stock price?
What are RGEN stock strengths?
What is RGEN Risk Level?
What is RGEN market cap and volume?
What is RGEN current Stock IQ?
Should I buy RGEN stock right now?
Is RGEN a Strong Buy right now?
What does a 'Strong Buy' rating mean for RGEN?
What does a 'Strong Sell' rating mean for RGEN?
What factors influence RGEN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.05%
+2.97%
+3.24%
+4.68%
+3.69%
RGEN
Repligen Corporation
Current Price
$167.93
Stock Insights
Strengths

Earnings are forecast to grow

RGEN Price Performance
$166.36 (+0.94%)
$161.1 (+4.24%)
$122.17 (+37.46%)
$161.86 (+3.75%)
RGEN Analysts Opinion
RGEN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
RGEN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RGEN Street Sentiment is extremely bullish and have negative views on the near-term outlook
RGEN has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Dec 16, 2025
Reiterate
Overweight
Barclays
Oct 30, 2025
Reiterate
Hold
Canaccord Genuity
Oct 30, 2025
Reiterate
Overweight
Barclays
Oct 02, 2025
Initiate
Buy
HSBC
Oct 01, 2025
Initiate
Buy
HSBC
RGEN Stock IQ
RGEN Latest Analysis
Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Wed Jan 14, 2026
Repligen Board Elects Martin Madaus As Chair . (RTTNews) - Repligen Corp. (RGEN) a life sciences company on Tuesday announced that its board has elected Martin Madaus as chair of the board effective March 13 following the retirement of Tony Hunt as Executive Chair and board member.
Tue Jan 6, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RGEN Stock trends
RGEN Stock performance
RGEN Stock analysis
RGEN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.